Reports have estimated that 12% of BC patients who developed the disease at ≤ 40 years were linked with PVs in BRCA1 or BRCA2 genes41–43, compared to global estimates of 3–4% of all women with BC18,44,45. This evidence concerns the gene BRCA2 and breast cancer.